Identification of circulating biomarkers for differentiating patients with papillary thyroid cancers from benign thyroid tumors
- 1 March 2021
- journal article
- research article
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 44 (11) , 2375-2386
Abstract
Background This study aimed to identify the potential circulating biomarkers of protein, mRNAs, and long non-coding RNAs (lncRNAs) to differentiate the papillary thyroid cancers from benign thyroid tumors. Methods The study population of 100 patients was classified into identification (10 patients with papillary thyroid cancers and 10 patients with benign thyroid tumors) and validation groups (45 patients with papillary thyroid cancers and 35 patients with benign thyroid tumors). The Sengenics Immunome Protein Array-combined data mining approach using the Open Targets Platform was used to identify the putative protein biomarkers, and their expression validated using the enzyme-linked immunosorbent assay. Next-generation sequencing by Illumina HiSeq was used for the detection of dysregulated mRNAs and lncRNAs. The website Timer v2.0 helped identify the putative mRNA biomarkers, which were significantly over-expressed in papillary thyroid cancers than in adjacent normal thyroid tissue. The mRNA and lncRNA biomarker expression was validated by a real-time polymerase chain reaction. Results Although putative protein and mRNA biomarkers have been identified, their serum expression could not be confirmed in the validation cohorts. In addition, seven lncRNAs (TCONS_00516490, TCONS_00336559, TCONS_00311568, TCONS_00321917, TCONS_00336522, TCONS_00282483, and TCONS_00494326) were identified and validated as significantly downregulated in patients with papillary thyroid cancers compared to those with benign thyroid tumors. These seven lncRNAs showed moderate accuracy based on the area under the curve (AUC = 0.736) of receiver operating characteristic in predicting the occurrence of papillary thyroid cancers. Conclusions We identified seven downregulated circulating lncRNAs with the potential for predicting the occurrence of papillary thyroid cancers.Keywords
Funding Information
- Chang Gung Memorial Hospital (CMRPG8I0451, CMRPG8I0452)
This publication has 66 references indexed in Scilit:
- The Landscape of long noncoding RNA classificationTrends in Genetics, 2015
- Long non-coding RNAs: new players in cell differentiation and developmentNature Reviews Genetics, 2013
- A Central Role for Long Non-Coding RNA in CancerFrontiers in Genetics, 2012
- American Association Of Clinical Endocrinologists, Associazione Medici Endocrinologi, And European Thyroid Association Medical Guidelines For Clinical Practice For The Diagnosis And Management Of Thyroid NodulesJournal of Endocrinological Investigation, 2010
- Evaluation of a Thyroid NoduleOtolaryngologic Clinics of North America, 2010
- Cytohistologic correlation of thyroid nodulesThe American Journal of Surgery, 2007
- Understanding diagnostic tests 3: receiver operating characteristic curvesActa Paediatrica, 2007
- Management of Thyroid Nodules Detected at US: Society of Radiologists in Ultrasound Consensus Conference StatementRadiology, 2005
- Ultrasound Thyroid Nodule Measurements: the “Gold Standard” and its Limitations in Clinical Decision MakingEndocrine Practice, 2003
- Thyroid malignancy in endemic nodular goitres: prevalence, pattern and treatmentEuropean Journal of Surgical Oncology, 2001